SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-052118
Filing Date
2021-04-19
Accepted
2021-04-19 21:13:07
Documents
2
Period of Report
2021-04-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2113474-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2113474-1_3seq1.xml 3 2217
2 EXHIBIT 24 tm2113474d1_ex24.htm EX-24 6367
  Complete submission text file 0001104659-21-052118.txt   10012
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address
McCarthy Reid (Reporting) CIK: 0001857733 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39202 | Film No.: 21836061